Journal article

Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition

MD Tate, JDH Ong, JK Dowling, JL McAuley, AB Robertson, E Latz, GR Drummond, MA Cooper, PJ Hertzog, A Mansell

Scientific Reports | NATURE PORTFOLIO | Published : 2016

Abstract

The inflammasome NLRP3 is activated by pathogen associated molecular patterns (PAMPs) during infection, including RNA and proteins from influenza A virus (IAV). However, chronic activation by danger associated molecular patterns (DAMPs) can be deleterious to the host. We show that blocking NLRP3 activation can be either protective or detrimental at different stages of lethal influenza A virus (IAV). Administration of the specific NLRP3 inhibitor MCC950 to mice from one day following IAV challenge resulted in hypersusceptibility to lethality. In contrast, delaying treatment with MCC950 until the height of disease (a more likely clinical scenario) significantly protected mice from severe and h..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

This work was supported by the Victorian State Government Operational Infrastructure Scheme. This work was supported by project grants awarded to AM, JLM and GD from the National Health and Medical Research Council of Australia (NHMRC: GNT1079924, GNT1062721 and GNT1062977). MDT was supported by an NHMRC Early Career Fellowship (1035733). MAC was supported by an NHMRC Australia Fellowship (511105). The authors thank R Smith with manuscript preparation.